ROADMAP GPS 360BECAUSE PATIENT INTELLIGENCE IS BUSINESS INTELLIGENCE
ROADMAP TECHNOLOGIESPLANNING AND FORECASTING SOLUTIONS
• Focus Industries
• Life Sciences
• Consumer Electronics
• Geneva Technology
• Predictive Analytics/Expert System for Forecasting
• Analytic Platform for RoadMap Solutions
• Licensed to Oracle, Samsung, CPFR Vendors
• RoadMap GPS 360
• Global Planning Solution
• Business Intelligence and Visualization, Guided Analytics, Scenario Planning and Modeling
ROADMAP GPS 360
Source Systems
ERP – Patient Records - EMR
Advanced Models, Forecasting Algorithms, Statistical Analysis
Patient Demographics and Cohort Groups
Patient Analytic Processing and De-Identification
Patient Intelligence Database
BUSINESS INTELLIGENCE/VISUALIZATION
ROADMAP GPS 360 – BECAUSE PATIENT INTELLIGENCE IS BUSINESS INTELLIGENCE
• Top Down Business Intelligence is Not Enough…
• Product / Market / Time
• Units / Revenue / Pricing
• NRX / TRX
• Accurate Planning Requires Patient Intelligence…
• Patient Persistency
• Daily Consumption (DACON) by Patient Cohort
• Market Segment by Disease State/Indication
LIFE SCIENCES – ANALYTIC OPPORTUNITY
• Specialty Drug RX and Revenue Forecasting
• Long and expensive development cycles
• Shorter product life cycles
• High long-term value to patient and provider when patient stays on treatment
• Patient-level modeling of initial prescription (“trials”)
• Patient-level modeling of ongoing treatment (“repeat”)
• Critical to model patient cohorts along the life-cycle
• Improved forecast accuracy returns millions profits for a typical brand
• Improved service levels and inventory positions, fewer out-of-stocks, improved
pricing and promotions
ROADMAP GPS 360 FOR LIFE SCIENCES
•Near perfect demand forecast accuracy (98-99%) for Specialty
Pharmaceuticals (e.g. Drugs for MS, RA, Oncology)
• Traditional approaches fall short
• Top-down forecasting models fail to capture patient-level demand and
usage profiles hindering accuracy
• Tools-based approaches (SAS, SPSS, R) must be augmented by expensive
analytical staff and/or consultancy
PATIENT ANALYTICS: DRILLING DOWN TO THE MOST IMPORTANT PATIENT CHARACTERISTICS AND BEHAVIORS
• Demographics
• Phenotype (Physical Characteristics)
•Genotype (Genetic Variations)
• Indication (Disease State)
• Patient Persistency
• DACON
PATIENT-BASED ANALYTICS
360 DEGREES OF BUSINESS INTELLIGENCE
Top Line
Sales
Analytics
Cohort
Analysis
DemosStatistics
Forecasts
PATIENT COHORT – GROUP OF PATIENTS WHO STARTED THERAPY IN THE SAME YEAR
0
200
400
600
800
1000
1200
1400
1600
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
New Patients to Therapy
PATIENT ANALYTICS
Patient Cohorts
Planning Scenarios
Patient Data Measures
ROADMAP GPS 360 - PATIENT COHORT ANALYSIS
SEAMLESS SWITCHING BETWEEN SALES AND PATIENT ANALYTICS
360 DEGREES OF BUSINESS INTELLIGENCE
Top Line
Sales
Analytics
Cohort
Analysis
DemosStatistics
Forecasts
DEMOGRAPHICS: PATIENT AGE
Patient AgeAge Distribution by Patient
Cohorts
PHENOTYPE: BODY MASS INDEX (BMI)
Patient BMI
Patient BMI
GENOTYPE: GENETIC MARKERS
Genetic Markers
360 DEGREES OF BUSINESS INTELLIGENCE
Top Line
Sales
Analytics
Cohort
Analysis
DemosStatistics
Forecasts
INCIDENCE: DISEASE STATE
Disease States
PATIENT PERSISTENCY OF THERAPY OVER TIME
Patient Persistency
360 DEGREES OF BUSINESS INTELLIGENCE
Top Line
Sales
Analytics
Cohort
Analysis
DemosStatistics
Forecasts
PATIENT PERSISTENCY: KEY TO FORECAST ACCURACY
• Accurate Forecasts of Patient Persistency Drive Refill RX Forecasts
• Refills Forecasts are Typically within 1-2% Accuracy
• Refills RX can be 90-95% of Total RX Prescriptions for a Chronic Condition
ROADMAP 360 KEY BENEFIT PROPOSITION
• Patient-level Intelligence and Insight Improves Understanding of Patient
Persistency and Adherence to Therapy
• Advanced 360 Analytics and Modeling Leads to Faster and Smarter
Organizational Decision Making
• Significant Bottom-line Impact through Measurable Improvements in Forecast
Precision